Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Yf-Vax Market Revenue Outlook: What CAGR Is Expected Through 2030?
The yf-vax market has experienced robust expansion in recent times, with projections indicating an increase from $6.78 million in 2025 to $7.32 million in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. This upward trend during the historical period is driven by factors such as yellow fever endemic zones, mandatory international travel vaccinations, established long-lasting immunity, governmental vaccination policies, and broader public health efforts.
The yf-vax market is projected to experience robust expansion in the coming years, reaching a value of $9.81 million by 2030 with a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is driven by factors such as a rise in international travel, the spread of mosquitoes influenced by climate change, broader immunization coverage, increased funding for outbreak readiness, and the expansion of public health surveillance systems. Key trends shaping this period include a growing demand for travel-related vaccinations, government-led immunization initiatives, the ongoing application of live attenuated vaccines, a heightened emphasis on preventing endemic diseases, and the strategic stockpiling of vaccines to prepare for potential outbreaks.
Download A Free Sample Report For Comprehensive Market Insights:
Yf-Vax Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing understanding of diseases spread by vectors is anticipated to boost the YF-Vax market in the coming period. These vector-borne illnesses are infectious conditions passed to people and animals through the bites of infected arthropods like mosquitoes, ticks, and fleas, which carry pathogens such as viruses, bacteria, or parasites, resulting in diseases like malaria, dengue, and Lyme disease. The increasing frequency of vector-borne diseases (VBDs) is driven by factors like climate change, urban development, higher global mobility, and growing mosquito populations, leading to a rise in reported outbreaks. YF-Vax offers effective prevention against yellow fever, a vector-borne illness, by activating the immune system to generate antibodies, ensuring durable protection from the virus spread by infected mosquitoes. As an example, in March 2024, the World Organization for Animal Health, a France-based intergovernmental body, noted that between 2023 and March 2024, vector-borne diseases triggered 2,422 outbreaks across 28 nations, with Europe recording 697 incidents. Consequently, heightened awareness of vector-borne diseases is fueling expansion in the YF-Vax market.
Yf-Vax Market Driver: Impact Of Rising Healthcare Spending On The Yf-Vax Market
The growth of the Yf-Vax market is expected to be driven forward by increasing healthcare expenditure. This spending is influenced by an aging demographic, progress in medical innovations, a higher incidence of chronic conditions, and a growing need for medical services. By delivering effective protection against yellow fever, YF-VAX helps lower healthcare costs by reducing expenses related to managing severe infections, hospital stays, and handling outbreaks. For instance, in May 2024, the Office for National Statistics, a UK government agency, reported that healthcare spending in the UK climbed by 5.6% between 2022 and 2023, compared to a 0.9% growth in 2022. In 2023, the UK’s healthcare expenditure reached around $317.63 billion (£292 billion). Thus, the rise in healthcare spending is propelling the expansion of the Yf-Vax market.
Yf-Vax Market Driver: Rising Demand For International Travel Fueling The Growth Of The Market Due To Increasing Preventive Vaccination Needs
The market for Yf-Vax is anticipated to be propelled forward by the growing desire for international travel. This type of travel involves moving from one country to another across borders for activities such as tourism, business, education, family visits, or other personal motives. The increasing demand for global travel stems from higher disposable incomes worldwide, which allow more individuals to spend on leisure pursuits, including trips abroad. International travel boosts the YF-Vax market by heightening the requirement for preventive shots among travelers heading to regions where yellow fever is prevalent. It stimulates vaccine adoption through mandatory immunization rules for entry, which helps safeguard against outbreaks and supports worldwide public health initiatives. As an illustration, in June 2025, FREETOUR.com, a travel services firm based in Switzerland, indicated that UK residents undertook more than 90 million overseas journeys in 2024, with projections of over 92 million outbound trips and 43.4 million international arrivals in 2025. Hence, the increasing demand for international travel is driving the Yf-Vax market forward.
Yf-Vax Market Segments: Where Are The Largest Growth Opportunities?
The yf-vax market covered in this report is segmented –
1) By Vaccine Type: Live Attenuated Vaccines, Fractional Dose Vaccine
2) By Transmission Type: Sylvatic Yellow Fever, Intermediate Yellow Fever, Urban Yellow Fever
3) By Distribution Channel: Hospitals, Retail Pharmacies, Government Health Programs
4) By End User: Adult, Geriatric, Pediatric
Yf-Vax Market Major Participants And Competitive Dynamics
Major companies operating in the yf-vax market are Sanofi S.A.
Access The Complete Yf-Vax Market Report:
Yf-Vax Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the yf-vax market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yf-vax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model